Claudia Capitini obtained her Master Degree in Medical and Pharmaceutical Biotechnology in April 2012 at the University of Florence (Italy), under the supervision of Professor Fabrizio Chiti, presenting a thesis on human TAR DNA-binding Protein 43 (TDP-43). In particular, the study focused on the biophysical and biochemical characterization of bacterial inclusion bodies of TDP-43. From October 2012 to December 2016 she worked as a Research Assistant through a contract with the University of Cambridge and the ELAN pharmaceutical company. At the same time, from November 2013, she was a PhD student in the Fabrizio Chiti’s group in Florence. During these years, she focused on the structural properties of the amyloid-like oligomeric intermediates formed by the bacterial HypF-N protein under different solution conditions, mainly using the Förster Resonance Energy Transfer (FRET) technique. Since May 2017, she is working as post-doc at LENS in collaboration with the Department of Biomedical Experimental and Clinical Science “Mario Serio”, within the project N2B-patch, aimed to characterize a potential therapeutic approach for the treatment of Multiple Sclerosis by means of biophysical methods.